How and When to Take Fisetin
Human fisetin studies use multiple schedules, and neither a high-fat meal nor morning dosing has been proved superior. This guide separates published trial procedures from practical supplement use, with special attention to bioavailability, timing and interaction uncertainty.
- Published
- Last reviewed
- Reading time
- 6 min
- Sources cited
- 9

On this page
There is no clinically established best meal or time of day for fisetin. Human pharmacokinetic evidence confirms poor oral exposure, but the key 2022 crossover study dosed participants after an overnight fast and fed them one hour later, so it does not prove that a fatty meal improves absorption. FISEKIN-1 is specifically testing fed versus fasted exposure [1] [8]. Human protocols also use several different dosing schedules, so this guide describes study procedures rather than presenting one regimen as a validated self-treatment protocol. For the full clinical context, see our complete clinician's guide.
How to take fisetin: quick answers
| Question | Evidence-based answer |
|---|---|
| With a meal or fat? | A fatty-meal absorption advantage has not been established in humans. The 2022 formulation study used fasting administration; see the pharmacokinetics. |
| Morning or evening? | No randomized human study identifies a preferred time. Follow the product label or individualized clinical instructions. |
| Split the daily dose? | Study regimens differ. There is no validated general rule for splitting high-dose fisetin. |
| Daily or intermittent? | Both appear in research for different purposes; neither is a proven self-treatment longevity regimen. Compare pulse protocols. |
| Combine with other supplements? | Mechanistic compatibility is not evidence of additive benefits or safety. Check the complete ingredient lists. |
| Taking medicines? | Seek prescriber or pharmacist review, especially with anticoagulants, antiplatelets, oncology drugs or narrow-therapeutic-index medicines. Interaction evidence. |
This page describes how studied protocols were administered; it does not prescribe an investigational high-dose protocol.
Should you take fisetin with food?
Human evidence has not established whether fisetin is absorbed better with a fatty meal than when taken fasted, or how much dietary fat, if any, would help. Fisetin has poor water solubility, which makes a food effect plausible, but plausibility is not proof of a dosing recommendation.
The 2022 human crossover study compared an unformulated product with the FF-20 hybrid-hydrogel formulation. Participants took each product after an overnight fast, with food provided later. It therefore demonstrated a formulation difference under the study's conditions, not a benefit from taking fisetin with 10–15 grams of fat [1].
If you use a fisetin supplement, follow its product instructions and discuss uncertain dosing questions with your clinician, particularly if you take medication. Different formulations may have different administration requirements; do not assume that an oil-containing meal or a specific amount of fat will reproduce the exposure reported with FF-20. FISEKIN-1 is investigating fed-versus-fasted pharmacokinetics [8]. See our bioavailability review for the distinction between solubility, measured exposure and clinical outcomes.
What time of day should you take fisetin?
No human trial has established that morning or evening use improves fisetin's efficacy, absorption or tolerability. Study schedules differ: some protocols specify morning administration, while REPROGRAM specifies fisetin with or just after an evening meal [6]. Neither is evidence of an optimal time for everyone. Follow the relevant product instructions or clinician-supervised study protocol.
Should you take fisetin every day or in pulses?
The single largest editorial fact about fisetin timing is not what time of day you take it — it is whether you take it every day or in short pulses. These are structurally different protocols with different scientific rationales.
Continuous daily dosing
Continuous daily dosing is used commercially and in some human research, but the studied doses and endpoints vary. Recent protocols include 100 mg/day, while 2026 obesity studies investigated 200 mg/day. Neither approach establishes an effective commercial daily dose, a proven longevity benefit or a generally applicable safety profile [9] [6].
High-dose intermittent schedules used in some human studies
Several senolytic-focused studies use short high-dose pulses, often around 20 mg/kg/day, but the schedules differ and the regimen has not been validated as a clinically effective human senolytic treatment. Other current human studies use lower intermittent or continuous doses. See our pulse-dosing evidence review for the protocol-by-protocol comparison.
Should you split the dose across the day?
No human trial has established that taking fisetin all at once is more effective or safer than dividing the same daily amount. Some research protocols specify one administration per day, but that describes a study procedure, not a validated rule for self-directed senolytic dosing.
There is no established human tissue-exposure threshold for senescent-cell clearance, and the effects of changing the dosing interval remain uncertain. Follow the instructions for the particular product or a clinician-supervised protocol rather than extrapolating from cell-culture peaks. Our pulse-dosing review compares the different schedules used in human research.
Can you take fisetin with other supplements?
Fisetin is often combined with other longevity supplements, but specific supplement stacks have not been adequately tested in humans. The absence of a documented interaction is not proof that a combination is safe or beneficial, particularly at high supplemental doses or alongside prescription medication.
Fisetin plus quercetin
These flavonols have overlapping mechanisms in laboratory models, but mechanistic overlap does not demonstrate that taking them together is safe or more effective in humans [5]. No established clinical interaction study defines the ideal timing or dose of a fisetin–quercetin stack. Our fisetin vs quercetin comparison separates individual-compound evidence from hypotheses about the combination.
Fisetin plus NMN
Fisetin and NMN are studied for different biological pathways, but the combination has not been tested in a controlled human trial. Human data do not establish an efficacy advantage, optimal timing or interaction profile for taking them together.
Fisetin plus spermidine
Fisetin is studied for senotherapeutic effects and spermidine for autophagy-related biology, but controlled human evidence for the combination is lacking. Spermidine is a polyamine, not a fat-soluble flavonoid. Our fisetin vs spermidine article compares the evidence without assuming that combining them produces an additive benefit.
Fisetin plus urolithin A
Fisetin is a flavonol studied for senotherapeutic effects; urolithin A is a gut-microbiome-derived ellagitannin metabolite studied for mitophagy. No controlled human interaction study has established the safety, efficacy or ideal timing of the combination. Our fisetin vs urolithin A article compares the evidence bases.
Fisetin plus prescription medications
Possible interactions with drug-metabolizing enzymes and transporters have been investigated mainly in preclinical models; the clinical relevance is uncertain. This uncertainty matters for anticoagulants, antiplatelet drugs and medicines with narrow therapeutic ranges. If you take prescription medication, check with your prescriber or pharmacist before using a concentrated fisetin supplement. See our drug-interactions review for the evidence by medication class.
Do you need to cycle fisetin?
There is no established clinical cycling schedule for fisetin supplementation. Some human senolytic-oriented trials include brief dosing periods separated by several weeks, while other studies examine continuous daily intake. Those differences reflect study-specific hypotheses and safety monitoring; they do not prove that a particular number of days on or off is necessary, safe or effective for general use.
Do not treat a 28-day break, monthly pulse or continuous regimen as a validated longevity protocol. Review the dose and schedule with a qualified clinician rather than copying an investigational trial.
How long before you feel anything?
Human studies have not established a predictable onset of noticeable benefits from fisetin. Senescence-related biomarkers, inflammation and physical-performance measures are being investigated, but changes in any one of them do not establish that an individual has experienced senescent-cell clearance.
Do not interpret immediate changes in energy, sleep or focus as proof that fisetin is working. Equally, feeling nothing cannot establish whether the supplement has or has not had a biological effect. There is no validated home test or personal hs-CRP target that confirms fisetin's proposed senolytic action.

Further reading: the actual doses used in human studies. Trial regimens should not be treated as universal dosing instructions.
What we still don't know
Meal effects. Whether fed versus fasted dosing or a particular fat source meaningfully changes exposure to unformulated fisetin in humans remains uncertain.
Time of day. Morning and evening dosing have not been directly compared for clinical benefit, exposure or tolerability.
Administration schedules. We do not know whether single versus divided doses, continuous use or any particular pulse interval improves clinical outcomes.
Supplement combinations. Human evidence is insufficient to establish the safety, pharmacokinetic interactions or added benefit of combining fisetin with quercetin, NMN, spermidine or urolithin A.
Bottom line
Human fisetin studies use multiple doses, schedules and meal conditions. Neither a high-fat meal nor morning dosing has been shown to be superior, and high-dose pulses should be understood as research protocols rather than a validated self-treatment regimen. If you use a supplement, follow the product label unless a clinician gives different advice, and be especially cautious with prescription medicines, pregnancy, breastfeeding or significant medical conditions. For evidence tier context, see our fisetin senolytic evidence review.
Frequently asked questions
Should I take fisetin on an empty stomach?
Can I take fisetin at night?
Should I take fisetin every day or in pulses?
Can I take fisetin with coffee?
How long does fisetin take to kick in?
Can I combine fisetin with quercetin?
Sources & article history
Sources (9)
-
Enhanced bioavailability and pharmacokinetics of a novel hybrid-hydrogel formulation of fisetin orally administered in healthy individuals: a randomised double-blinded comparative crossover study Journal of Nutritional Science. 2022;11:e74.
-
Fisetin is a senotherapeutic that extends health and lifespan EBioMedicine. 2018;Volume 36, pages 18–28.
-
Alleviation by Fisetin of Frailty, Inflammation, and Related Measures in Older Women (AFFIRM) ClinicalTrials.gov (trial registry record — not yet published in a peer-reviewed journal). 2018;Not applicable — registry record.
-
Fisetin for COVID-19 in skilled nursing facilities: Senolytic trials in the COVID era Journal of the American Geriatrics Society. 2021;69:3023-3033.
-
Fisetin as a Senotherapeutic Agent: Biopharmaceutical Properties and Crosstalk between Cell Senescence and Neuroprotection Molecules. 2022;Volume 27, page 738.
-
REPROGRAM: REsilience PROmotion with GeRoprotectors: AssessMent of biological effect: Rationale and protocol for a trial of biological effect PLOS ONE. 2026;21(6):e0346347.
-
Fisetin to Improve Vascular Function in Older Adults ClinicalTrials.gov trial registry record. 2023.
-
A Comparison of Fisetin Kinetics in Young and Old Adults (FISEKIN-1) ClinicalTrials.gov trial registry record. 2025.
-
Low-Dose Fisetin Supplementation and Its Association With Chronic Inflammation in Middle-Aged and Older Adults: Study Protocol for a Triple-Blind, Randomised, Placebo-Controlled Trial Basic & Clinical Pharmacology & Toxicology. 2026;139(3):e70290.
Article history (1)
- Updated the discussion of meal timing, dosing schedules and interaction uncertainty.




